Event Registration

Summary

Are you looking for a translationally relevant preclinical platform to evaluate human T cell immunomodulatory therapies? Peripheral blood mononuclear cell (PBMC)-engrafted NSG* mice serve as a robust model for studying T cell activation, immune modulation, and therapeutic intervention. These models play a critical role in research on graft-versus-host disease (GvHD), immuno-oncology, and much more.

In this webinar, we will explore:

The importance of immunotherapies in disease treatment
Key differences between PBMC and CD34+ stem cell engraftment
Comparison of NSG and NSG-MHC I/II DKO models for studying immune responses
Applications beyond immuno-oncology: Utility of PBMC-engrafted models in autoimmune and infectious disease research

*NSG is a registered trademark in the USA and other countries

JAX™ Webinars are complimentary.
No fees will be charged for registering.

Webinars are 45-50 minutes long, followed by a Q&A session.

When registering, please use an institutional (e.g. work, university, etc.) email address or contact our event staff to request an exception. Thank you.

Advancing Immunotherapy Research with PBMC-Engrafted NSG Models

When registering, please use an institutional (e.g. work, university, etc.) email address or contact our event staff to request an exception. Thank you.